BVF Partners
Biotech Investor · 3 portfolio companies
Portfolio
3
Combined Value
$1.3B
Focus Areas
5
Top Stage
Phase 3
Portfolio Companies
| Company | Valuation |
|---|---|
| Olema Pharmaceuticals | $1.3B |
| Aro Biotherapeutics | — |
| Plexium | — |
Biotech Investor · 3 portfolio companies
| Company | Valuation |
|---|---|
| Olema Pharmaceuticals | $1.3B |
| Aro Biotherapeutics | — |
| Plexium | — |